XM does not provide services to residents of the United States of America.

Bath & Body Works forecasts smaller drop in annual sales on strong holiday demand



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Bath & Body Works forecasts smaller drop in annual sales on strong holiday demand</title></head><body>

Nov 25 (Reuters) -Bath & Body Works BBWI.N on Monday raised its forecast for full-year adjusted profit and said it expects a smaller drop in annual sales, helped by steadfast demand for its personal care products and new offerings in its stores, sending the retailer's shares up about 12% in premarket trading.

The Ohio-based company introduced new products including its new winter range of fragrances such as Winter Candy Apple and Frosted Coconut Snowball to keep up with competition and help tackle softer demand in the retail industry in the quarter.

An uptick in sales during the quarter, especially in it fragrance offerings, has resulted from the company's efforts to push the brand as affordable luxury, particularly among younger customers.

"We believe we are well-positioned to navigate a volatile retail environment and shorter holiday calendar," said CEO Gina Boswell in a statement.

Bigger rivals Estee Lauder EL.N and L'Oreal OREP.PA were pulled down by waning demand as consumers restrained spending on their premium beauty products and upmarket lipsticks and perfumes.

Bath & Body Worksnow expects net sales to shrink to a range of 1.7% to 2.5% for full-year 2024, compared with a prior forecast of a 2%-to-4% decline.

Bath & Body Works expects annual adjusted earnings per share between $3.15 and $3.28, compared with a prior forecast of between $3.06 and $3.26 per share.

On an adjusted basis, Bath & Body Works posted a profit of 49 cents per share for the quarter ended Oct. 28, above analysts' average estimates of 47 cents per share, according to data compiled by LSEG.

The company's third-quarter sales rose 3% to $1.61 billion, beating estimates of $1.58 billion.



Reporting by Neil J Kanatt in Bengaluru; Editing by Shailesh Kuber

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.